Sadeçolak, M. et al. 2026. Increased Risk of Hepatitis B Virus Reactivation in Patients with Resolved Hepatitis B Virus Infection Receiving Combination Immunosuppressive Therapy: The Role of Anti-HBs Status. Turkish Journal of Gastroenterology. 37, 7 (Jun. 2026), 793–801. DOI:https://doi.org/10.5152/tjg.2026.26167.